Crossover Fund

Crossover Fund

A mutual fund that invests in both publicly-traded companies and private equity. A crossover fund usually has higher risk than most mutual funds, depending on the types of companies in which it invests, but it normally has both high yield and growth. Crossover funds are considered better as long-term investments, rather than short-term.
References in periodicals archive ?
Since its founding, Sharecare has grown to more than 2600 employees across 29 offices globally; closed 13 strategic acquisitions; and raised more than $400 million in total capital to date from investors extending from the living room to doctors exam rooms and into the workplace, including hospitals, health care investment firms and health plans: in particular, HCA (NYSE:HCA), Trinity Health, the Heritage Healthcare Innovation Fund and CareFirst; media companies Discovery Communications, Harpo Productions, Remark Holdings and Sony Pictures Television; high growth technology investment firms such as Claritas Capital; noted crossover fund Wellington Management; Wells Fargo; and Swiss Re, one of the worlds largest reinsurance providers.
"We are now very excited to have WestBridge Crossover Fund, one of the leading PE investors in India, partner with us to help build out this vision for work spaces of the future," said co-founder and chairman, IndiQube, Rishi Das.
Currently, Van Wagoner Ventures is marketing its VW Crossover Fund III Transportation Infrastructure to institutions and individuals interested in the rapid transformation of the global transportation grid.
The round also received participation from an unnamed public crossover fund as well as from existing investors SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology Ventures.
Including the debt capital raised in this most recent round, Sharecares strategic investors include hospitals, health care investment firms and health plans, in particular, HCA (NYSE:HCA), Trinity Health, the Heritage Healthcare Innovation Fund and Hawaii Medical Service Association (HMSA); media companies Discovery Communications, Harpo Productions and Sony Pictures Television; high growth technology investment firms such as Claritas Capital; noted crossover fund Wellington Management; Wells Fargo; and Swiss Re, one of the worlds largest reinsurance providers.
Catabasis' SMART Linker technology is intended to conjugate two therapies that act on different components of a disease pathway seeking to produce new chemical entities with enhanced efficacy, safety and tolerability profile.Country: USASector: PharmaceuticalsTarget: Catabasis Pharmaceuticals IncBuyer: Lightstone Ventures, SV Life Sciences, Unnamed public crossover fund, Clarus Ventures, MedImmune Ventures, Advanced Technology VenturesDeal size in USD: 32.4mType: VCStatus: Closed